Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients

被引:1
|
作者
Morales-Orue, Ignacio [1 ,2 ,3 ]
Zafra-Martin, Juan [3 ]
Garcia, Laura [3 ]
Chicas-Sett, Rodolfo [3 ]
Castilla-Martinez, Juan [3 ]
Auxiliadora Cabezon, Maria [3 ]
Burgos, Javier [4 ]
Lloret, Marta [3 ]
Lara, Pedro C. [4 ,5 ]
机构
[1] Punta Europa Hosp, Dept Radiat Oncol, Carretera Getares S-N, Algeciras 11207, Spain
[2] Punta Europa Hosp, Dept Med Oncol, Algeciras, Spain
[3] Dr Negrin Univ Hosp Gran Canaria, Dept Radiat Oncol, Las Palmas Gran Canaria, Spain
[4] San Roque Univ Hosp, Dept Oncol, Las Palmas Gran Canaria, Spain
[5] Fernando Pessoa Canarias Univ, Fac Hlth Sci, Las Palmas Gran Canaria, Spain
关键词
Stereotactic ablative radiotherapy (SABR); elderly; oligometastatic; radiotherapy; breast; BODY RADIATION-THERAPY; QUALITY-OF-LIFE; BRAIN METASTASES; COMBINATION CHEMOTHERAPY; INTERNATIONAL SOCIETY; GERIATRIC ASSESSMENT; FOLLOW-UP; RADIOSURGERY; ONCOLOGY; SBRT;
D O I
10.21037/tcr.2019.08.29
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer (BC) is the principal cause of cancer-related death in women. Metastatic patients are usually treated with a systemic therapy, but clinical results are limited. Oligometastatic subjects can benefit from high-precision radiotherapy techniques to potentially achieve a complete response. Currently, there is limited evidence of stereotactic ablative radiotherapy (SABR) treatments in elderly oligometastatic cancer patients. A review of the medical literature was performed in PubMed database to assess the current role of SABR in the treatment of breast oligometastases in elderly patients. SABR represents a feasible and safe therapeutic approach in oligometastatic elderly BC patients. Further studies are required to establish the optimum patient selection and treatment scheme.
引用
收藏
页码:S197 / S206
页数:10
相关论文
共 50 条
  • [21] Stereotactic radiation therapy for breast cancer in the elderly
    Jardel, Pauline
    Kammerer, Emmanuel
    Villeneuve, Hugo
    Thariat, Juliette
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 : S86 - S96
  • [22] Single-Fraction Stereotactic Ablative Body Radiotherapy for Primary and Extracranial Oligometastatic Cancers
    Greenwood, H.
    Hassan, J.
    Fife, K.
    Ajithkumar, T. V.
    Jayaprakash, K. Thippu
    CLINICAL ONCOLOGY, 2023, 35 (12) : 773 - 786
  • [23] The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer
    Guerrero, Eduardo
    Ahmed, Merina
    LUNG CANCER, 2016, 92 : 22 - 28
  • [24] Monte Carlo calculation of dose distributions in oligometastatic patients planned for spine stereotactic ablative radiotherapy
    Moiseenko, V.
    Liu, M.
    Loewen, S.
    Kosztyla, R.
    Vollans, E.
    Lucido, J.
    Fong, M.
    Vellani, R.
    Popescu, I. A.
    PHYSICS IN MEDICINE AND BIOLOGY, 2013, 58 (20): : 7107 - 7116
  • [25] Advances in Radiobiology of Stereotactic Ablative Radiotherapy
    Qiu, Bin
    Aili, Abudureyimujiang
    Xue, Lixiang
    Jiang, Ping
    Wang, Junjie
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [26] Safety and Survival Rates Associated With Ablative Stereotactic Radiotherapy for Patients With Oligometastatic Cancer A Systematic Review and Meta-analysis
    Lehrer, Eric J.
    Singh, Raj
    Wang, Ming
    Chinchilli, Vernon M.
    Trifiletti, Daniel M.
    Ost, Piet
    Siva, Shankar
    Meng, Mao-bin
    Tchelebi, Leila
    Zaorsky, Nicholas G.
    JAMA ONCOLOGY, 2021, 7 (01) : 92 - 106
  • [27] Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer
    Ricardi, Umberto
    Levra, Niccolo Giaj
    Badellino, Serena
    Alongi, Filippo
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2235 - 2237
  • [28] Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
    Weykamp, Fabian
    Koenig, Laila
    Seidensaal, Katharina
    Forster, Tobias
    Hoegen, Philipp
    Akbaba, Sati
    Mende, Stephan
    Welte, Stefan E.
    Deutsch, Thomas M.
    Schneeweiss, Andreas
    Debus, Juergen
    Hoerner-Rieber, Juliane
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [29] Cost-Effectiveness Analysis of Stereotactic Ablative Radiation Therapy in Patients With Oligometastatic Cancer
    Kumar, Abhishek
    Straka, Christopher
    Courtney, Patrick T.
    Vitzthum, Lucas
    Riviere, Paul
    Murphy, James D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 109 (05): : 1185 - 1194
  • [30] Efficacy of stereotactic ablative radiotherapy in patients with oligometastatic hepatocellular carcinoma: A phase II study
    Choi, Seo Hee
    Lee, Byung min
    Kim, Jina
    Kim, Do Young
    Seong, Jinsil
    JOURNAL OF HEPATOLOGY, 2024, 81 (01) : 84 - 92